EP2522354
Methods to reduce adverse events caused by pharmaceutical preparations comprising plasma derived proteins
:
EP einkaleyfi: Þýðing ekki lögð inn:
12.5.2011:
23.8.2017:
11165869.6
:
11.5.2031
:
Methods to reduce adverse events caused by pharmaceutical preparations comprising plasma derived proteins
12.5.2011
23.8.2017
:
CSL Behring GmbH:
Emil-von-Behring-Strasse 76, 35041, Marburg, DE
:
Schulte, Stefan:
Marburg, DE
:
Kalina, Uwe:
Marburg, DE
:
Moses, Michael:
Grävenwiesbach, DE
:
Feussner, Annette:
Marburg, DE
:
A61K 31/727, A61K 35/16, A61K 38/57, A61P 7/02, A61P 1/00, A61P 11/08, A61P 9/06, A61P 9/12